Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    weill AND qatar | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Genetics of Mendelian Diseases in Qatar
Condition: Mendelian Disorders
Intervention:
2 Recruiting Qatar Universal Diabetes Outcomes (QUDOS) Study
Conditions: Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention:
3 Recruiting Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes
Conditions: Charcot Arthropathy;   Type 2 Diabetes
Intervention:
4 Recruiting DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention:
5 Not yet recruiting HbA1c Variability in Type II Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Metformin;   Drug: Gliclazide;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Pioglitazone;   Drug: Dapagliflozin;   Drug: human insulin
6 Recruiting Next Generation DNA Sequencing in Patients With Idiopathic Male Infertility
Condition: Infertility
Intervention:
7 Recruiting Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis
Condition: Systemic Inflammatory Response Syndrome
Intervention:
8 Not yet recruiting Impact of a Pharmacist-delivered Discharge and Follow-up Intervention for Patients With Acute Coronary Syndromes in Qatar
Condition: Acute Coronary Syndromes
Intervention: Behavioral: Structured intervention at discharge and tailored follow up post discharge
9 Recruiting Depression, Obesity and Inflammatory Markers
Conditions: Bipolar Disorder;   Depression;   Obesity
Intervention: Drug: Minocycline

Study has passed its completion date and status has not been verified in more than two years.